Concepedia

Hyacinth C. Akunne

HC

37

Publications

1.5K

Citations

25

H-Index

1987

Active since

Affiliations

Pfizer (United States)(Current)

National Institutes of Health

Florida Agricultural and Mechanical University

National Institute on Drug Abuse

University of Groningen

Hyacinth C. Akunne is an author at Pfizer (United States) specializing in medicine, pharmacology, and neuropharmacology.

Top concepts

Publications per year

1987–2011

37

Publications

37

Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.

Thomas A. Pugsley, M. Duff Davis, Hyacinth C. Akunne et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 201 citations

GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine

Richard B. Rothman, Andrea Mele, Audrey A. Reid et al. · Pharmacology Biochemistry and Behavior · 1991 · 127 citations

, , +9

Substituted [(4-Phenylpiperazinyl)- methyl]benzamides:  Selective Dopamine D<sub>4</sub> Agonists

Shelly A. Glase, Hyacinth C. Akunne, Lynn M. Georgic et al. · Journal of Medicinal Chemistry · 1997 · 105 citations · Full text

, , +15

Identification of a GBR12935 homolog, LR1111, which is over 4,000‐fold selective for the dopamine transporter, relative to serotonin and norepinephrine transporters

Richard B. Rothman, Bruce Lewis, Chris Dersch et al. · Synapse · 1993 · 73 citations

, , +22

Affinity for Dopamine D<sub>2</sub>, D<sub>3</sub>, and D<sub>4</sub>Receptors of 2-Aminotetralins. Relevance of D<sub>2</sub>Agonist Binding for Determination of Receptor Subtype Selectivity

L. Alexander van Vliet, Pieter G. Tepper, Durk Dijkstra et al. · Journal of Medicinal Chemistry · 1996 · 68 citations · Full text

, , +16

Rows per page

1–5 of 37